Strategic Blueprint’s MiMedx Group MDXG Stock Holding History

Strategic Blueprint’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300	Closed	-$4K	–	935
2021 Q2	$4K	Buy	+300	New	+$3.25K	﹤0.01%	1123

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Strategic Blueprint's MDXG Position: Q3 2021 in Review

Strategic Blueprint sold out of MiMedx Group (MDXG) in Q3 2021, closing a stake of 300 shares — an estimated $4K sold.

Strategic Blueprint first reported a position in MDXG in Q2 2021 and held it in 1 quarter. The position peaked at $4K in Q2 2021. 142 funds tracked by Wall St. Rank hold MDXG as of Q3 2021.

Strategic Blueprint reported no remaining MiMedx Group position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 300 MiMedx Group shares in Q3 2021, an estimated $4K.
Strategic Blueprint first reported a position in MiMedx Group in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's MiMedx Group position peaked at $4K in Q2 2021.
142 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.